Related Experiment Videos
[Diabetes and mitochondrial cytopathies: pathological studies]
J Mikol1, P J Guillausseau, P Massin
1Services d'Anatomie et Cytologie Pathologiques, de Médecine B et d'Ophtalmologie, Hôpital Lariboisière, Paris. jacqueline.mikol@lrb.ap-hop-paris.fr
Annales De Pathologie
|December 6, 2005
Summary
Maternal inherited diabetes and deafness (MIDD) is a progressive condition linked to a specific gene mutation, often involving multiple organ systems and macular changes.
Area of Science:
- Genetics
- Mitochondrial Diseases
- Ophthalmology
Context:
- Maternal inherited diabetes and deafness (MIDD) is a maternally inherited condition.
- It is characterized by progressive neural deafness and diabetes mellitus.
- The condition is associated with the A3243G mutation in the mitochondrial tRNA leucine gene.
Purpose:
- To describe the clinical and pathological features of MIDD.
- To highlight the systemic involvement and genetic basis of MIDD.
- To differentiate MIDD from other mitochondrial disorders.
Summary:
- MIDD is a progressive syndrome featuring neural deafness and diabetes, linked to the A3243G mitochondrial DNA mutation.
- Characteristic macular pattern dystrophy and muscular lesions are observed.
- Mitochondrial abnormalities occur in various organs, including the pancreas, heart, and kidneys, with variable heteroplasmy.
Impact:
- Understanding MIDD's progressive nature and multi-system involvement is crucial for patient management.
- Recognizing MIDD's association with other mitochondrial syndromes like MELAS and Kearns-Sayre syndrome aids in diagnosis.
- Identifying the specific genetic mutation provides insights into mitochondrial disease pathogenesis.